Fredericamycin derivatives as medicaments for treating tumours

US7244741B2 · kind B2 · utility

Assignee

• Biofrontera Discovery GmbH · DE

Inventors

• Werner Simon · Seeheim-Jugenheim, DE
• Ulrich Abel · Schifferstadt, DE

Key dates

• Filing date: Jul 9, 2003
• Grant date: Jul 17, 2007
• Expiry date: Sep 10, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel fredericamycin derivatives of general formula (Ia) or (Ib), to medicaments containing the fredericamycin derivatives or salts thereof, and to the use of the fredericamycin derivatives for treating diseases, especially tumor diseases.